303 related articles for article (PubMed ID: 36734855)
41. [Lnc-TMEM132D-AS1 overexpression reduces sensitivity of non-small cell lung cancer cells to osimertinib].
Zhao Q; Wang N; Li Y; Wu Q; Wu L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):242-250. PubMed ID: 36946044
[TBL] [Abstract][Full Text] [Related]
42. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
[TBL] [Abstract][Full Text] [Related]
43. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.
Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y
J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726
[TBL] [Abstract][Full Text] [Related]
44. LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1.
Li C; Zhao W; Pan X; Li X; Yan F; Liu S; Feng J; Lu J
Oncogene; 2020 Sep; 39(39):6157-6171. PubMed ID: 32820252
[TBL] [Abstract][Full Text] [Related]
45. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A; Wang J
DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
[TBL] [Abstract][Full Text] [Related]
46. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
[TBL] [Abstract][Full Text] [Related]
47. Long noncoding RNA regulatory factor X3- antisense RNA 1 promotes non-small cell lung cancer via the microRNA-577/signal transducer and activator of transcription 3 axis.
Hu Y; Zhao Z; Jin G; Guo J; Nan F; Hu X; Hu Y; Han Q
Bioengineered; 2022 Apr; 13(4):10749-10764. PubMed ID: 35475457
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
[TBL] [Abstract][Full Text] [Related]
49. Long noncoding RNA MCF2L-AS1 promotes the cancer stem cell-like traits in non-small cell lung cancer cells through regulating miR-873-5p level.
Li S; Lin L
Environ Toxicol; 2021 Jul; 36(7):1457-1465. PubMed ID: 33783940
[TBL] [Abstract][Full Text] [Related]
50. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p.
Wu W; Zhao Y; Gao E; Li Y; Guo X; Zhao T; He W; Zhang H
J Cell Mol Med; 2020 Jan; 24(1):441-450. PubMed ID: 31721438
[TBL] [Abstract][Full Text] [Related]
51. NEAT1/hsa-mir-98-5p/MAPK6 axis is involved in non-small-cell lung cancer development.
Wu F; Mo Q; Wan X; Dan J; Hu H
J Cell Biochem; 2019 Mar; 120(3):2836-2846. PubMed ID: 29095526
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
53. Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.
Li J; Li Y; Sun X; Wei L; Guan J; Fu L; Du J; Zhang X; Cheng M; Ma H; Jiang S; Zheng Q; Wang L
Mol Carcinog; 2024 Apr; 63(4):757-771. PubMed ID: 38289172
[TBL] [Abstract][Full Text] [Related]
54. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
[TBL] [Abstract][Full Text] [Related]
56. LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression.
Shen Q; Jiang Y
Biomed Pharmacother; 2018 Sep; 105():176-181. PubMed ID: 29857296
[TBL] [Abstract][Full Text] [Related]
57. Regulating COX10-AS1 / miR-142-5p / PAICS axis inhibits the proliferation of non-small cell lung cancer.
Tang X; Wu Y; Yang J; Zhu W
Bioengineered; 2021 Dec; 12(1):4643-4653. PubMed ID: 34323174
[TBL] [Abstract][Full Text] [Related]
58. Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).
Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y
Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947
[TBL] [Abstract][Full Text] [Related]
59. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer.
Miao S; Wang J; Xuan L; Liu X
Biofactors; 2020 Jul; 46(4):600-607. PubMed ID: 32049388
[TBL] [Abstract][Full Text] [Related]
60. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
